Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Neuropace Inc
NPCECurrent price
9.68 USD
-0.19 USD (-1.93%)
Last closed
9.15 USD
Company
www.neuropace.com
ISIN
US6412881053
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
219 269 472 USD
Yield for 12 month
+11.26 %
1Y
3Y
5Y
10Y
15Y
NPCE
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California. Address: 455 North Bernardo Avenue, Mountain View, CA, United States, 94043
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
15.5 USDP/E ratio
–Dividend Yield
–Current Year
+65 421 000 USD
Last Year
+45 520 000 USD
Current Quarter
+19 256 000 USD
Last Quarter
+18 124 000 USD
Current Year
+48 122 000 USD
Last Year
+32 493 000 USD
Current Quarter
+14 134 000 USD
Last Quarter
+13 343 000 USD
Key Figures NPCE
1 year
3 years
5 years
10 years
EBITDA
-24 597 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-15.75 %
PEG Ratio
–
Return On Equity TTM
-192.19 %
Wall Street Target Price
15.5 USD
Revenue TTM
71 819 000 USD
Book Value
0.34 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
16.6 %
Dividend Yield
–
Gross Profit TTM
32 493 000 USD
Earnings per share
-1.08 USD
Diluted Eps TTM
-1.08 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-41.63 %
Dividend Analytics NPCE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NPCE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation NPCE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
3.3054
Price Sales TTM
3.0531
Enterprise Value EBITDA
-16.9437
Price Book MRQ
22.182
Financials NPCE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NPCE
For 52 weeks
5.45 USD
18.15 USD
50 Day MA
6.82 USD
Shares Short Prior Month
532 846
200 Day MA
9.76 USD
Short Ratio
9.2
Shares Short
509 203
Short Percent
3.64 %
BeatStart